NeuroPace, Inc. (NPCE)
NASDAQ: NPCE · Real-Time Price · USD
17.06
+0.38 (2.28%)
May 27, 2026, 4:00 PM EDT - Market closed
NeuroPace Market Cap
NeuroPace has a market cap or net worth of $581.64 million as of May 28, 2026. Its market cap has increased by 32.82% in one year.
Market Cap
581.64M
Enterprise Value
598.12M
1-Year Change
32.82%
Ranking
Category
Stock Price
$17.06
Market Cap Chart
Since the IPO on April 22, 2021, NeuroPace's market cap has increased from $393.28M to $581.64M, an increase of 47.89%. That is a compound annual growth rate of 7.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 27, 2026 | 581.64M | 13.10% |
| Dec 31, 2025 | 514.27M | 53.97% |
| Dec 31, 2024 | 334.00M | 23.25% |
| Dec 29, 2023 | 270.98M | 630.30% |
| Dec 30, 2022 | 37.11M | -84.86% |
| Dec 31, 2021 | 245.09M | -37.68% |
| Apr 22, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bioventus | 743.46M |
| Lumexa Imaging Holdings | 741.74M |
| CeriBell | 709.53M |
| SI-BONE | 641.29M |
| BrainsWay | 627.37M |
| Tactile Systems Technology | 565.49M |
| Cerus | 565.04M |
| Beta Bionics | 518.25M |